Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS.

Neurology - 28 May 2013

Killoran Annie, Biglan Kevin M, Jankovic Joseph, Eberly Shirley, Kayson Elise, Oakes David, Young Anne B, Shoulson Ira

Abstract excerpt

OBJECTIVES: We aimed to describe the clinical phenotype conferred by the intermediate-length huntingtin allele CAG repeat expansion in a population-based study. METHODS: The Prospective Huntington At Risk Observational Study (PHAROS) enrolled adults at risk for Huntington disease (HD). They were assessed approximately every 9 months with the Unified Huntington's Disease Rating Scale (UHDRS) by investigators...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cognition
Share to Huntingtin Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Huntington Disease

Share to Motor Activity

Share to Nerve Tissue Proteins

Share to Psychiatric Status Rating Scales

Share to Trinucleotide Repeat Expansion

Source

Open in PubMed Open full text

Identifiers

PMID: 23624566
DOI: 10.1212/WNL.0b013e318294b304
PMCID: PMC3716408

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS.PMID 23624566Read ↗

Clinical manifestations of intermediate allele carriers in Huntington disease.Semantic proximity Read ↗

Intermediate CAG repeats in Huntington‘s Disease: Analysis of COHORTSemantic proximity Read ↗

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.Semantic proximity Read ↗

Phenotype Characterization of HD Intermediate Alleles in PREDICT-HD.Semantic proximity Read ↗

Exploring the correlates of intermediate CAG repeats in Huntington disease.Semantic proximity Read ↗

The clinical phenotype of carriers of intermediate alleles in the huntingtin gene: A scoping review.Semantic proximity Read ↗

Characterization of a large group of individuals with huntington disease and their relatives enrolled in the COHORT study.Semantic proximity Read ↗

Prevalence of Carriers of Intermediate and Pathological Polyglutamine Disease–Associated Alleles Among Large Population-Based CohortsSemantic proximity Read ↗

Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort.Semantic proximity Read ↗

Analysis of HTT CAG repeat expansion among healthy individuals and patients with chorea in Korea.Semantic proximity Read ↗

Huntingtin gene intermediate alleles influence the progression from subjective cognitive decline to mild cognitive impairment: A 14-year follow-up study.Semantic proximity Read ↗

Evidence‐based genetic counselling implications for Huntington disease intermediate allele predictive test resultsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.